Fri, Jul 11, 2014, 11:38 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • jhn_benton jhn_benton Apr 16, 2006 4:21 PM Flag


    This guy Lawyler is just like after eatting a lot of beans . NOISE. LMAO

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • deashus Apr 16, 2006 10:01 PM Flag

      He has a hedge fund out of NJ and from his photo seems a little young (even though he's an MD)to be an "expert" in anything, let alone a specialist in this particular field. He more than likely is seeing the release on HEP-C testing in the next couple weeks and was hoping for a much lower pps at which to cover. They've been battling this thing lower in the early and late trading time frames and expending much more than I'm sure they anticipated.
      Alpert's sarcastic lead-in and the 'less than enlightening' jab by Lawyler was clealy intended to be self-serving.
      I would keep my eyes on insider action. That will tell you if things are going south with testing and management has started to throw in the towell. I have seen only the contrary.
      JMO but 6.87 on the pps isn't expensive for a biotech stock with AVII's potential. The market will pay a much higher premium for positive results, and that's why we're all here now.

21.98-0.56(-2.48%)Jul 11 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Potbelly Corporation
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT
ACI Worldwide, Inc.
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT
MGIC Investment Corp.
NYSEFri, Jul 11, 2014 4:01 PM EDT